Highlights
- 1
- 2JAMA network open · 2023
- 3Drug and alcohol dependence · 2020
Publications
48 publications
Funding
20 grantsView NIH portfolio on RePORTER ↗
Active
15 grants- Co-IThe Ohio Valley Node of the Clinical Trials Network - MOMs ProjectNational Institute on Drug Abuse · 2025–2032 · via University of CincinnatiUG1DA013732-26
- Sub-PITesting MOUD Scale-Up Strategies in Criminal Legal SettingsNational Institute on Drug Abuse · 2025–2030 · via University of WisconsinUM1DA064515-02
- Sub-PINY MOVES: Evaluating the Impact of New York's Methadone Outreach VEhicleSNational Institute on Drug Abuse · 2025–2030 · via New York UniversityR01DA063711-02
- Sub-PIImproving Jail Response to the Overdose Crisis: A Hybrid Trial of Jail ECHO to Improve MOUD Implementation and Public Health OutcomesNational Institute on Drug Abuse · 2025–2030 · via University of Massachusetts Medical SchoolRM1DA064507-02
- Co-IHealth Economics of Substance Use Disorder, HCV, and HIV Treatment: Supporting Financial Sustainability, Advanced Methods, and Knowledge TranslationNational Institute on Drug Abuse · 2025–2030P30DA040500-12
- MPINY Community-Hospital-Academic Maternal Health Equity Partnerships (NY-CHAMP) Component: Project 2 - Policy solutions for addressing structural racism in maternal heath disparitiesEunice Kennedy Shriver National Institute of Child Health and Human Development · 2023–2029 · via Columbia UniversityU54HD113172-03
- Co-IA Randomized Controlled Trial of sublingual versus extended-release buprenorphine with individuals leaving Carceral Settings access, quality, and spendingNational Institute on Drug Abuse · 2023–2028 · via Friends Research Institute, Inc.R01DA058674-01
- Sub-PINAVIGATE Kidney: A Multi-Level Intervention to Reduce Kidney Health DisparitiesNational Institute of Diabetes and Digestive and Kidney Diseases · 2023–2028 · via University of Colorado Denver Anschutz Medical CampusU01DK137272-03
- Sub-PILeveraging social determinants via artificial intelligence and peer coaching to address racial disparities in primary care among people who use opioidsAgency for Healthcare Research and Quality · 2023–2027 · via Friends Research Institute, Inc.R18HS029783-02
- PINovel Econometric Research Designs (NERD) to Help End Addiction Long-termNational Center for Advancing Translational Sciences · 2024–2027DP2DA062283-01
- Co-IJCOIN Phase II Economic Research Resource CenterNational Institute on Drug Abuse · 2025–2027U24DA064506-01
- Sub-PIReducing Addiction through Prevention Infrastructure Development (RAPID)National Institute on Drug Abuse · 2025–2026 · via Wayne State UniversityR61DA063683-01
- PIThe Economic Viability and Value of Implementing an Inpatient Addiction Consult Model in Public Hospital Systems for Patients with Opioid Use DisorderNational Institute on Drug Abuse · 2023–2026R03DA057465-02
- Co-IA Randomized Controlled Trial of sublingual versus extended-release buprenorphine with individuals leaving Carceral SettingsNational Institute on Drug Abuse · 2022–2026 · via Friends Research Institute, Inc.
- Co-IGreater Southern California Node of the Clinical Trials NetworkNational Institute on Drug Abuse · 2022–2026 · via University of California, Los AngelesUG1DA049435-04
Completed grants (5)
- PIHealth-related quality of life among persons involved in the criminal-legal system with a history of opioid use disorderChestnut Health Systems Inc. · 2023–2025ContractSRA 230561-02
- Co-IAddressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populationsNational Institute on Drug Abuse · 2020–2025 · via Yale UniversityU01DA053039-01
- Co-IComparative- and cost-effectiveness research determining the optimal intervention for advancing transgender women living with HIV to full viral suppressionNational Institute on Drug Abuse · 2023–2025 · via Friends Research Institute, Inc.R01DA056287-01
- Co-IOptimizing PrEP Implementation and Cost-effectiveness among Sexual and Gender Minority Individuals with a Substance Use DisorderNational Institute on Drug Abuse · 2022–2025 · via Friends Research Institute, Inc.R01DA056888-01
- Co-IDAT-18-06 Prevention and Rescue Of Fentanyl and Other Opioid Overdoses Using Optimized Naloxone Distribution Strategies (PROFOUND)National Institute on Drug Abuse · 2019–2025
Honors & distinctions
1 honor
- NIH Director's New Innovator Award · National Institutes of Health · 2024
Clinical research
1 study
Active
1 study- PIEconomic evaluation of NY MOVES: Evaluating the Impact of New York's Methadone Outreach VEhicleSNew York University School of Medicine · OPEN TO ACCRUAL (as of 2026)
News mentions
1 mentionView all WCM news ↗
- Dr. Ali Jalali Receives NIH Director’s New Innovator AwardOctober 10, 2024
Dr. Ali Jalali, an assistant professor of population health sciences at Weill Cornell Medicine, was awarded the prestigious National Institutes of Health Director’s New Innovator Award through its Helping to End Addiction Long-term (HEAL) Initiative.
Mentoring
1 menteeAll publications with mentees →
- CCCallista ClairmontMD mentee · Class of 2026